International Graphite (ASX: IG6) strikes European graphite processing JV with Italian chemical group ALKEEMIA at Porto Marghera
Infosys agrees to acquire Optimum Healthcare IT for $465m in its second-largest deal, targeting AI-led transformation of US provider market
The Las Vegas Strip just got a pricing experiment, and MGM Resorts International is betting guests will notice
Read More 6 minute read Pharma Industry News CERo Therapeutics moves forward in Phase 1 AML study as CER-1236 passes first-dose safety review CERo Therapeutics completes first cohort of its Phase 1 AML trial with no dose-limiting toxicities—discover how CER-1236 could reshape immunotherapy. bySoujanya RaviOctober 13, 2025